.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Cipla
Johnson and Johnson
Cantor Fitzgerald
Citi
Express Scripts
McKinsey
Daiichi Sankyo
Julphar
Healthtrust

Generated: June 27, 2017

DrugPatentWatch Database Preview

Details for Biologics License Application 125388

« Back to Dashboard

Summary for BLA: 125388

Tradename:
ADCETRIS
Applicant:
Seattle Genetics
Ingredient:
brentuximab vedotin
Patents:8
Approval Date:Aug 19, 2011
Suppliers: see list1

Pharmacology for BLA: 125388

Ingredient-typeImmunoconjugates
Drug ClassCD30-directed Immunoconjugate
Mechanism of ActionCD30-directed Antibody Interactions
Physiological EffectMicrotubule Inhibition
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Inventors Patent Expiration Status Orphan Source
Seattle Genetics
ADCETRIS
brentuximab vedotin
INJECTABLE; INJECTION1253880012011-08-198,722,019 biOasis Technologies, Inc. (Vancouver, British Columbia, unknown) Jefferies; Wilfred (South Surrey, CA), Tian; Mei Mei (Coquitlam, CA), Vitalis; Timothy (Vancouver, CA) ► SubscribeRXsearch
Seattle Genetics
ADCETRIS
brentuximab vedotin
INJECTABLE; INJECTION1253880012011-08-199,272,052 SEATTLE GENETICS, INC. (Bothell, WA) Lewis; Timothy S. (Bothell, WA), Law; Che-Leung (Bothell, WA), McEarchern; Julie A. (Bothell, WA) ► SubscribeRXsearch
Seattle Genetics
ADCETRIS
brentuximab vedotin
INJECTABLE; INJECTION1253880012011-08-199,364,567 biOasis Technologies, Inc. (Richmond, CA) Vitalis; Timothy Z. (Vancouver, CA), Gabathuler; Reinhard (Montreal, CA) ► SubscribeRXsearch
Seattle Genetics
ADCETRIS
brentuximab vedotin
INJECTABLE; INJECTION1253880012011-08-199,447,431 CureVac AG (Tubingen, DE) Thess; Andreas (Kusterdingen, DE), Schlake; Thomas (Gundelfingen, DE), Probst; Jochen (Wolfschlugen, DE) ► SubscribeRXsearch
Seattle Genetics
ADCETRIS
brentuximab vedotin
INJECTABLE; INJECTION1253880012011-08-199,457,019 Deciphera Pharmaceuticals, LLC (Lawrence, KS) Flynn; Daniel L. (Lawrence, KS), Kaufman; Michael D. (Lawrence, KS), Smith; Bryan D. (Lawrence, KS), Rudoltz; Marc (West Orange, NJ) ► SubscribeRXsearch
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
AstraZeneca
Argus Health
Daiichi Sankyo
Chinese Patent Office
Chubb
McKesson
UBS
Express Scripts
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot